Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Aethlon Medical Inc

AEMD ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Advanced Medical Equipment & Technology ·

USA Micro Cap Analyst: HOLD

Last Close

$2.83

▼ -3.41%

Market Cap $2.01M · Vol 8.27K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$2.01M

Micro Cap

Div Yield

N/A

EPS Growth

+71.87%

YoY

RSI (14)

50.34

Momentum

Beta

1.37

vs Market

52W High

$136.50

97.93% below

52W Low

$2.64

7.26% above

Volume

8.27K

Avg 5.85K

P/B

0.70

Price-to-book

ROE

N/A

Return on equity

Free Float

95.84%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Aethlon Medical Inc (AEMD) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does AEMD pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-10.16%

-17.37%

-73.55%

-71.12%

YTD

-79.57%

-95.16%

-99.79%

-99.98%

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-7,151,470.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-104.46% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	0.70
P/FCF	N/A
EPS Growth	+71.87%
Outstanding Shares	711.14K

Technical Indicators

50-Day SMA	$4.97
200-Day SMA	$11.55
RSI (14)	50.34
Beta	1.37
52-Week High	$136.50
52-Week Low	$2.64

Volume Today	8.27K
Avg Daily Volume (30D)	5.85K
Relative Volume	1.41x
Volatility (10D)	70.96
Volatility (30D)	85.76
Free Float	95.84%

Analyst Consensus

HOLD

Current Price $2.83

Mean Target $10.00

52W Low$2.64 52W High$136.50

Current

Target

$2.64 $136.50

Current Analyst target

+253.36% upside potential · 3 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001SDDHJ6

ISINUS00808Y6041

CountryUnited States of America

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateNov 12, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -1.28% DHR Danaher Corp -0.71% ISRG Intuitive Surgical Inc -1.68% BSX Boston Scientific Corp +0.27% EW Edwards Lifesciences Corp -1.04%

Company Profile

Aethlon Medical, Inc. is a clinical-stage medical device company. The Company is focused on advancing the Hemopurifier (HP), a clinical-stage immunotherapeutic device intended for applications in cancer, life-threatening viral infections, and organ transplantation and other areas of significant unmet needs. In pre-clinical studies, the Hemopurifier has exhibited the capacity to remove harmful extracellular vesicles (EVs) and enveloped viruses from biological fluids, utilizing its proprietary lectin-based mechanism. These extracellular vesicles have been implicated in disease processes such as immune suppression and metastasis in cancer as well as in the progression of severe life-threatening infectious diseases. The United States Food and Drug Administration (FDA) has designated the Hemopurifier as a Breakthrough Device for the treatment of individuals with advanced or metastatic cancer who are unresponsive to or intolerant of standard of care therapy.